While some studies suggest potential benefits of certain cardiovascular disease supplements, the overall scientific evidence regarding their efficacy remains a subject of ongoing research and discussion. The American Heart Association and other health organizations emphasize the importance of obtaining essential nutrients from a well-balanced diet rather than relying solely on supplements. Dietary patterns that include fruits, vegetables, whole grains, lean proteins, and healthy fats are considered fundamental for cardiovascular health. Supplements are typically recommended when there is a deficiency or specific medical indication. It's essential for individuals to approach cardiovascular disease supplements with caution, understanding that these products are not a substitute for a healthy lifestyle and medical management as prescribed by healthcare providers. Moreover, individual responses to supplements can vary, and excessive intake of certain vitamins or minerals may have adverse effects. Regular communication with healthcare professionals is key to making informed decisions about the use of cardiovascular disease supplements based on individual health needs and circumstances.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India